Goldman Steven Harold 4/A
4/A · STELLAR PHARMACEUTICALS INC · Filed Sep 14, 2012
Insider Transaction Report
Form 4/AAmended
Goldman Steven Harold
Director
Transactions
- Purchase
Common Shares
2012-09-07$0.50/sh+25,000$12,500→ 1,130,146 total(indirect: Lambent Consulting Corp)